Major Rating Factors:
Fair reserve development (4.0 on a scale of 0 to 10) as the level of reserves has at times been insufficient to cover claims. In 2020 and 2021 the two year reserve development was 18.5% and 27.0% deficient respectively. Fair profitability index (2.9) with operating losses during 2020 and the first three months of 2025. Average return on equity over the last five years has been poor at -4.5%. Poor long-term capitalization index (1.7) based on weak current risk adjusted capital (severe loss scenarios), although results have slipped from the fair range during the last year.
Other Rating Factors:
Good overall results on stability tests (5.1) despite weak risk adjusted capital in prior years. Strengths include potentially strong support from affiliation with The Doctors Co an InterIns Exchange. The largest net exposure for one risk is conservative at 2.0% of capital. Superior liquidity (10.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
G - Fast asset or premium growth.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
DC
Principal Investments:
Investment grade bonds (93.7%), cash (4.3%), other (2.0%)
Corporate Info
Group Affiliation
The Doctors Co an InterIns Exchange
Investment Rating
--
Company Address
185 Greenwood Road
Napa, CA 94558
Napa, CA 94558
Phone Number
(707) 226-0100
NAIC Number
14347
Website
Largest Affiliates